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An Autosomal-Recessive Form of Cutis Laxa Is Due to
Homozygous Elastin Mutations, and the Phenotype
May Be Modified by a Heterozygous Fibulin 5
Polymorphism
Hala Me´garbane´1,2, Jobard Florence3, Jo¨rn Oliver Sass4, Susanne Schwonbeck3, Mario Foglio3,
Rafael de Cid3, Susan Cure5, Safa Saker6, Andre´ Me´garbane´2,7 and Judith Fischer3
Cutis laxa (CL) is a heterogeneous group of connective tissue disorders characterized by loose, sagging skin and
variable involvement of other organs. Autosomal-dominant forms are relatively mild, and may be caused by
mutations in the elastin gene, whereas the more severe recessive forms have been associated with mutations in
the fibulin 4 and fibulin 5 genes, as well as in a vesicular ATPase subunit. We describe here a previously
unreported autosomal-recessive form of CL caused by homozygous recessive mutations in exon 12 of the
elastin gene (p.P211S) in three patients from two related consanguineous Syrian families. Furthermore, we
found that the presence of a polymorphism in the fibulin 5 gene in one of the patients seems to modify the
phenotype, producing more severe symptoms. This polymorphism (p.L301M) was associated with mild
symptoms in the mother of the patient, who was heterozygous for both the elastin and fibulin 5 mutations.
To our knowledge, autosomal-recessive CL owing to homozygous mutations in the elastin gene has not been
reported previously.
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INTRODUCTION
Inherited cutis laxa (CL) is a heterogeneous group of
connective tissue disorders characterized by loose, sagging,
inelastic skin and variable involvement of internal organs. A
deficiency of dermal elastic fibers and reduced elastin
synthesis have been described in cultured fibroblasts from
CL patients (Olsen et al., 1988; Sephel et al., 1989). The
clinical spectrum of CL includes autosomal-dominant CL
(ADCL; OMIM 123700), autosomal-recessive CL (ARCL)
types I and II (OMIM 219100 and 219200, respectively),
and X-linked forms (OMIM 304150). The X-linked recessive
CL with skin laxity, and skeletal and genitourinary tract
abnormalities is identical to Ehlers–Danlos syndrome type IX,
and both conditions are now known as occipital horn
syndrome. This form is caused by mutation in the Cu(2þ )-
transporting ATPase, a-polypeptide ATP7A.
ADCL is a relatively mild cutaneous disease (Beighton,
1972) in which gastrointestinal diverticuli, hernias, or genital
prolapse may occur (Damkier et al., 1991). Other rare
symptoms are pulmonary artery stenosis, aortic and arterial
dilatation and tortuosity, Raynaud’s phenomenon, bronch-
iectasis, and emphysema (Hayden et al., 1968; Beighton,
1972; Weir et al., 1977; Tsuji et al., 1990; Corbett et al.,
1994; Tassabehji et al., 1998). Patients with ADCL have
heterozygous mutations in the elastin gene (ELN) (Tassabehji
et al., 1998; Zhang et al., 1999), which are all situated in the
C-terminal end of the gene between exons 22 and 34. There
are other disorders in which heterozygous mutations of
elastin are transmitted in an autosomal-dominant manner: (i)
supravalvular aortic stenosis is an allelic form of ADCL with
loss-of-function mutations in ELN and (ii) the contiguous gene
syndrome, Williams–Beuren syndrome (WBS), is caused by
large deletions in chromosome 7q11 which contains the ELN
gene. WBS symptoms include mental retardation and
neurobehavioral features, but only 5–10% of these patients
present supravalvular aortic stenosis.
The ARCL forms, which are known to date, are less
frequent but more severe; they involve vital organ systems
and are often lethal. ARCL type I is associated with a
generalized disorder of elastic tissue, leading to pulmonary
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emphysema, umbilical, inguinal and diaphragmatic hernias,
and gastrointestinal and vesico-urinary tract diverticuli for
which homozygous missense mutations in the fibulin 5
(FBLN5) gene were initially identified in a large Turkish family
(Loeys et al., 2002). Two patients with ARCL type I and
mutations in fibulin 4 (FBLN4) have also been described; these
patients present very severe phenotypes, including multiple
bone fractures at birth, ascending aortic aneurysm, and other
typical ARCL symptoms (Hucthagowder et al., 2006), or lethal
pulmonary artery occlusion, aortic aneurysm, arachnodactyly,
and mild CL (Dasouki et al., 2007). ARCL type II is associated
with joint laxity, developmental delay, pre- and postnatal
growth delay, large fontanels with delayed closure, and
congenital hip dislocation. Recently, however, mutations in
the gene ATP6V02 have been described in several families
with type II CL or wrinkly skin syndrome, which results from
abnormal glycosylation of serum proteins such as congenital
defect of glycosylation (CDG-II), causing impairment of Golgi
trafficking in fibroblasts (Kornak et al., 2008).
We report here an autosomal-recessive form of ARCL in
two related families including four patients. The three
patients who were available for molecular analysis (P1, P2,
and P4) present homozygous missense mutations in ELN.
Furthermore, in one of the patients (P1), an additional
heterozygous sequence variation in FBLN5 was found, which
seems to modify the phenotype, producing a more severe
form of the disease.
RESULTS
Clinical features
The two families (Figure 1a) belong to the Syrian Christian
community and were from the same village in Syria. They
stated that they were related, but the exact degree of
relationship could not be determined. The parents of the
affected children were all first cousins.
Family 1
The female patient (P1) was born after an uneventful
pregnancy by Cesarean section at 40 weeks because of
sudden hypertension in the mother. The parents were under
30 years old at the time of her birth. Family history included
one early miscarriage. The birth weight was 2,700 g (50th
percentile) and height was 47 cm (10th percentile). The
presence of a redundant loose skin, especially evident on the
face, the thorax, the abdomen, and the dorsum of the hands
and feet, was observed at birth. According to the mother, the
anterior fontanel was unusually wide and closed only at the
age of 25 months. Developmental milestones were delayed
as the child started speaking a few words only at 28 months
and could stand with help only at 3 years of age. Clinical
examination at 3 years revealed a height of 83 cm (5th
percentile), a weight of 15.5 kg (75th percentile), and an
occipital-frontal circumference (OFC) of 48.5 cm (25th
percentile). She had a hoarse voice and an appearance of
early aging. Her skin appeared prematurely aged, lax,
wrinkled, but inelastic all over the body (Figure 1b, left
and middle panels). She had low-set and large ears, anteverted
nares, drooping cheeks, a small mouth, and microretrognathia.
Increased joint laxity was also noted. Palms, soles, and
external genital organs were normal. Neurological and
ophthalmological examinations, as well as abdominal ultra-
sound, were normal. Echocardiography showed the presence
of a small ostium secundum. She had a normal karyotype. At
the age of 5 years, she could walk alone, but could still speak
only a few words (mental retardation). The voice was slightly
harsh. Her height was 105cm (10th percentile), her weight
was 22kg (90th percentile), and her OFC was 50cm (25th
percentile). Complete clinical examination of the parents was
normal, including the appearance of the skin, but joint laxity
was observed in the mother.
Five years later, a boy (P4 in Figure 1a) was born at term
after an uneventful pregnancy by Cesarean section. The birth
weight was 3,300 g (50th percentile) and the height was
51 cm (10th percentile). He was examined for the first time by
our dermatologist (H.M.) at the age of 13 months, at which
time his height was 76 cm (50th percentile), his weight was
12.5 kg (90th percentile), and his OFC was 47.2 cm (75th
percentile). Developmental milestones were within normal
limits, and he could already walk without help. He had large
ears, microretrognathia, and redundant loose, lax, wrinkled,
but inelastic skin all over the body (Figure 1b, right panel).
No joint laxity was observed; the neurological examination
was normal and there was no evidence of mental retardation.
Family 2
Patient 2 (P2 in Figure 1a) was born at term after an
uneventful pregnancy. At birth, his weight was 3,100 g (35th
percentile) and his height was 47 cm (5th percentile). The
presence of redundant loose skin was especially evident on
the face, the lower abdomen, and the dorsum of the hands
and feet. Developmental milestones were within the normal
limits. The anterior fontanel closed at the age of 8 months.
We examined him at the age of 8 years, at which time his
height was 117 cm (5th percentile) and his weight was 20 kg
(5th percentile). He had an appearance of early aging. The
skin appeared lax and wrinkled all over the body. In addition,
he had large ears, a beaked nose, thin lips, small teeth,
drooping cheeks, and severe myopia. No joint laxity was
noted. Neurological examination, abdominal ultrasound,
echocardiography, and external genitalia were normal.
Patient 3 (P3 in Figure 1b) is the first cousin of patient P2.
His medical history reported birth at term after an uneventful
pregnancy, redundant loose skin at birth, and developmental
milestones within normal limits. Our first examination, at the
age of 32 years, revealed an appearance of early aging with
lax and wrinkled skin on the dorsum of the hands and on the
neck, large ears, but no joint laxity. No heart malformations
were known, but he refused further investigation including
genetic testing. His parents were healthy and did not present
any of the abnormal features described.
In our patients, no supravalvular aortic stenosis or other
heart defect was found except for a small ostium secundum in
patient P1. A large deletion, such as those found in WBS, has
been excluded in patient P1 who suffers from mental
retardation. The phenotype of patients P2, P3, and P4 is
strictly limited to the skin.
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Sialotransferrin pattern
To exclude a defect of glycosylation, we analyzed the
sialotransferrin pattern of a serum sample from patient P1
by ion-exchange HPLC. The chromatogram showed a normal
sialotransferrin pattern. The percentages of the glycosylated
fractions of transferrin in patient P1 were normal and the
reference ranges for transferrin isoelectric focussing reported
by Morava et al. (2008) are given in brackets: monosialo-
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FBLN5: p.[L301M]+[wt]
ELN:  p.[P211S]+[wt]
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Figure 1. Pedigrees with phenotypic characteristics of the patients, and genetic analysis of elastin and fibulin 5. (a) Pedigrees of affected families. (b)
Phenotypic characteristics. Photographs of patient 1 (P1, left and middle panels) taken at the age of 1 year and at 3 years 8 months, showing the redundant
hanging skin over the lower part of the face, the upper and lower limbs, thorax, and abdomen. The photograph of patient 4 (P4, right panel) taken at the age of 13
months. (c) Sequence electropherograms. Mutation analysis revealed one mutation in ELN with a C-T transition at cDNA position 631, resulting in a
replacement of proline by serine at amino acid position 211 (p.P211S). The mutation is homozygous in patients P1 and P2, and heterozygous in the father (F) and
in the mother (M) of family 1. The control DNA (C) is homozygous for the wild type. Patient P1 and her mother (M) carry the heterozygous sequence variation in
FBLN5 (c.901C-A), which is predicted to result in an amino acid change at position 301 (p.L301M). (d) Sequence alignment of elastin and fibulin peptides.
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transferrin not detected (0–3.0), disialotransferrin 0.88
(1.0–6.0), 3.24 trisialotransferrin (3.0–16). The sum of the
percentages of mono- and disialotransferrins (%CDT) was
below 1.64% and thus within the normal range provided by
the manufacturer of the test kit.
Genetic analysis
Initially, only patient P1 and her parents were available for
molecular analysis, and no information about further affected
family members was known. As the parents were not
obviously affected and the patient presented a phenotype
concordant with ADCL, our first hypothesis was a neo-
mutation in the C-terminal end of ELN. However, sequencing
of exons 22–34 revealed no mutations. We therefore
performed mutation analysis in other genes known to be
implicated in CL. The analysis of FBLN5 revealed one
heterozygous missense mutation in patient P1 and her
mother, which replaced a cytosine at position 901 by an
adenine (c.901C-A), resulting in a change from leucine to
methionine at amino acid position 301 (p.L301M) in exon 9.
A genome-wide scan of this family using Affymetrix Gene
chip 50K arrays revealed a 12Mb long homozygous region
on chromosome 7, which contains the ELN gene. We
therefore performed sequence analysis of the remaining
exons 1–21 of the ELN gene, and detected in the patient a
homozygous missense mutation in exon 12, which changes a
cytosine at position 631 to thymine (c.631C-T), resulting in
a replacement of proline by serine at position 211 (p.P211S).
In a search for further relatives of this family, we received
information about distant cousins in Syria (family 2), but they
exhibited a milder phenotype than our index patient P1. A DNA
analysis of one of the cousins (P2) showed that he was also
homozygous for the same c.631C-T mutation in ELN, but he
did not exhibit any sequence variation in FBLN5. Clinical
examination of the second child in family 1 (P4) was performed
only recently, at the age of 13 months. He presented with a mild
form of CL, and genetic analysis revealed homozygous ELN
mutations (p.P211S), but no mutations in FBLN5.
Sequencing of 100 control DNA samples from a Syrian and a
Lebanese population failed to reveal any of the sequence
variations in ELN and FBLN5 that we found in these families.
DISCUSSION
No familial cases with autosomal-recessive transmission of
ELN mutations have been described to date. We analyzed
two related families including three consanguineous nuclear
families (four patients). The three patients who were available
for genetic analysis showed homozygous ELN mutations, and
the unaffected parents (available for analysis only in family 1)
were heterozygous for this mutation. This constellation
corresponds to an autosomal-recessive mode of inheritance,
which is underlined by the fact that homozygous ELN
mutations were observed in three patients from the two
related families. Furthermore, there is evidence for modifica-
tion of the phenotype in one of these families owing to a
polymorphism in FBLN5.
Elastic fibers consist of microfibrillar components and
elastin. The characteristic elasticity of many tissues depends
on the elastin component in the extracellular matrix. Elastin is
largely composed of glycine, proline, and other hydrophobic
residues. It contains multiple lysine-derived crosslinks, such
as desmosines, which link the individual polypeptide chains
to form a rubber-like network. The hydrophobic regions of
the chains between the crosslinks are highly mobile. The
hydrophobic and crosslinking domains are coded by sepa-
rate, small (27–114 bp) exons that are separated by large
introns. A total of 11 isoforms are listed in the UniProt
database for the ELN gene with a maximum of 34 exons,
which code for a total of 724 amino acids. The initial
translation product is a polypeptide of 72 kDa, designated
tropoelastin. In AD forms of elastin disorders, a 50%
reduction in expression is sufficient to provoke a phenotype.
In the form of ARCL described here, it is not yet clear why the
CL phenotype manifests only when both alleles are mutated.
Furthermore, a FBLN5 sequence variation in patient P1,
which was transmitted by the mother, may be the cause of a
more severe phenotype in this patient and of minimal
symptoms observed in the mother who transmitted this
FBLN5 mutation. No symptoms were observed in the father
who carries one heterozygous ELN mutation, but not the
FBLN5 polymorphism. We recently reported a patient with
homozygous FBLN5 mutations (Claus et al., 2008) in which
the parents also presented minimal CL symptoms, mainly
slightly sagging cheeks and deep nasogenien grooves. This
observation is in contrast to the findings of Loeys et al. (2002),
Markova et al. (2003), and Hu et al. (2006), who did not
report symptoms in heterozygous carrier parents.
Fibulin 5 is a modular calcium-binding extracellular matrix
protein with a molecular mass of 56 kDa. It contains an N-
terminal calcium-binding epidermal growth factor-like domain
with an Arg-Gly-Asp cell-adhesion motif, five contiguous
calcium-binding epidermal growth factor-like domains, and a
C-terminal fibulin-type module (Freeman et al., 2005). It plays
important roles in elastic fiber formation, in linking elastic
fibers to cells, in vascular cell signaling and migration, and in
regulating superoxide dismutase in blood vessels (Midwood
and Schwarzbauer, 2002; Nakamura et al., 2002; Yanagisawa
et al., 2002; Nguyen et al., 2004; Spencer et al., 2005). Besides
ARCL, mutations in the fibulin 5 gene can also cause age-
related macular degeneration when present in the hetero-
zygous state (Stone et al., 2004). In addition to the FBLN5
knockout mouse, which has a viable phenotype, there are
currently several informative murine models for elastic fiber
diseases. The elastin-null mouse has proved to be a good
model of supravalvular aortic stenosis in the heterozygous
state, including some cutaneous manifestations (Li et al., 1998;
Milewicz et al., 2000; Wendel et al., 2000). The lysyl oxidase-
null mouse, although presenting effects on both collagens and
elastin, also provides insights into the assembly and role of the
elastic fiber network in the skin and other organs (Ma¨ki et al.,
2005). Most recently, the knockout of fibulin 4 has shown
dramatic lethal perinatal defects in elastic fiber assembly in the
skin and in all other elastic tissues (McLaughlin et al., 2006).
Fibulin 4 mutations represent another cause of CL, (Huctha-
gowder et al., 2006) even if effects are some times too severe
for survival (Dasouki et al., 2007).
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Hu et al. (2006) reported a case of acquired CL in a 12-
year-old boy with compound heterozygous ELN missense
mutations p.[A55VþG773D] and a heterozygous mutation
in FBLN5 p.[G202R]. The patient developed first symptoms
after a parasitic infection by Toxocara canis; a histological
examination of his skin biopsies showed inflammatory
destruction of elastic fibers. The authors suggested that
interaction between variants in ELN and FBLN5 may result
in an elastic fiber system susceptible to inflammatory
degradation. In our four patients, no history of inflammatory
disease or parasitism was known, and in all cases the CL
phenotype was present at birth.
Our patients (P1, P2, and P4) displayed homozygous
missense mutations in elastin p.[P211S], which leads to a
replacement of proline—a non-polar amino acid—with
serine, which is a polar non-charged amino acid with a
hydroxyl group. This proline is situated in a region that is
highly conserved in humans (Homo sapiens), cattle (Bos
taurus), mice (Mus musculus), rats (Rattus norvegicus), and
zebrafish (Danio rerio), but is different in chicken (Gallus
gallus) and fruit flies (Drosophila melanogaster) (Figure 1d).
The sequence variation we found in FBLN5 p.[L301M] (in
P1 and her mother) replaces leucine by methionine, both of
which are non-polar amino acids. The leucine at this position
in FBLN5 is conserved in most species, such as humans,
chimpanzees (Pan troglodytes), cattle, dogs (Canis familiaris),
and chicken. However, the leucine residue is not conserved
in mice and rats, or in other FBLN paralogues such as FBLN1,
FBLN2, and FBLN7.
To our knowledge, this is the first description of a mild CL
phenotype with an autosomal-recessive form of inheritance.
Furthermore, unlike the reported cases of mild CL owing to
autosomal-dominant alleles in which the mutations are in the
C-terminal portion of elastin (exons 22–34), our patients had a
mutation in exon 12. These findings have important
consequences for genetic testing and counseling of patients,
and mutation analysis should be extended to all exons of the
gene. This situation indicates once again that there are no
fixed rules for the behavior of genes and proteins, and that
new mechanisms and phenotypes can be revealed even with
a small number of well-analyzed patients.
MATERIALS AND METHODS
Clinical data and pedigree information for the families were
recorded by the dermatologist H.M. (the Dermatology Medical
Center) and the geneticist A.M. (the Medical Genetic Unit, the
Medical Faculty at Saint-Joseph University, Beirut, Lebanon). The
medical ethical committee of Inserm (France) approved the
described study; blood was collected from each participating family
member after obtaining written informed consent. DNA was
extracted from peripheral blood leukocytes at Ge´ne´thon’s DNA
Bank or from mouth swabs (P2 and P4) using standard procedures.
The Declaration of Helsinki Principles was respected.
Mutation screening
Mutation analysis was performed in affected patients, both parents
and non-affected siblings. We designed intronic oligonucleotide
primers flanking the exons for amplification and sequencing of ELN
and FBLN5 using the Primer3 program (http://frodo.wi.mit.edu). The
touch-down PCR reaction was carried out in a 45 ml volume
containing 50 ng of genomic DNA (in 5ml) with a Hot Master Taq
DNA polymerase (Eppendorf, France): the initial denaturation step
was performed at 95 1C for 5minutes, followed by six cycles of
amplification consisting of 40 seconds at 94 1C, 30 seconds at 68 1C,
and a 30-second elongation step at 72 1C, followed by 30 cycles of
40 seconds at 94 1C, 30 seconds at optimal annealing temperature,
30 seconds at 72 1C, and a 5-minute terminal elongation step.
Purified PCR products (1–2ml) were added to 0.5 ml of sense or
antisense primer (20mM) and 2 ml of a BigDye terminator mix
(Applied Biosystems, France) in a 15 ml volume. The linear
amplification consisted of an initial 5-minute denaturation
step at 96 1C, 25 cycles of 10 seconds of denaturation at 96 1C,
and a 4-minute annealing/extension step at 56–60 1C. The reaction
products were purified and sequenced on an Applied Biosystems
Sequencer 3730. Forward or reverse strands from all patients and
controls were sequenced for the entire coding region and
exon–intron boundaries. The sequences were analyzed using the
Phred Phrap program on Unix.
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